Susanna Kemppainen

Susanna Kemppainen


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012 in Neurobiology of Aging
Verified
Journal Article
Closed access
SKSusanna Kemppainen
Susanna Kemppainen
TRTomi Rantamäki
Tomi Rantamäki
AJAndré Jerónimo-Santos
André Jerónimo-Santos
GLGregoire Lavasseur
Gregoire Lavasseur
HAHenri Autio
Henri Autio
HTHeikki Tanila
Heikki Tanila

18 July 2011 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
Mikko HiltunenMikko Hiltunen
Mikko Hiltunen
VKVinoth K. M. Khandelwal
Vinoth K. M. Khandelwal
NYNagendra Yaluri
Nagendra Yaluri
TTTea Tiilikainen
Tea Tiilikainen
MTMaija Tusa
Maija Tusa
HTHeikki Tanila
Heikki Tanila
According to epidemiological studies, type‐2 diabetes increases the risk of Alzheimer’s disease. Here, we induced hyperglycaemia in mice overexpressing mutant amyloid precursor protein and presenilin‐1 (APdE9) either by cross‐breeding them with pancreatic insulin‐like growth factor 2 (IGF‐2) overexpressing mice or by feeding them with high‐fat diet. Glucose and insulin tolerance tests revealed significant hyperglycaemia in mice overexpressing IGF‐2, which was exacerbated by high‐fat diet. However, sustained hyperinsulinaemia and insulin resistance were observed only in mice co‐expressing IGF‐2 and APdE9 without correlation to insulin levels in brain. In behavioural tests in aged mice, APdE9 was associated with poor spatial learning and the combination of IGF‐2 and high‐fat diet further impaired learning. Neither high‐fat diet nor IGF‐2 increased β‐amyloid burden in the brain. In male mice, IGF‐2 increased β‐amyloid 42/40 ratio, which correlated with poor spatial learning. In contrast, inhibitory phosphorylation of glycogen synthase kinase 3β, which correlated with good spatial learning, was increased in APdE9 and IGF‐2 female mice on standard diet, but not on high‐fat diet. Interestingly, high‐fat diet altered τ isoform expression and increased phosphorylation of τ at Ser202 site in female mice regardless of genotype. These findings provide evidence for new regulatory mechanisms that link type‐2 diabetes and Alzheimer pathology.

3 July 2013 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TRTomi Rantamäki
Tomi Rantamäki
SKSusanna Kemppainen
Susanna Kemppainen
HAHenri Autio
Henri Autio
SSSaara Stavén
Saara Stavén
HKHennariikka Koivisto
Hennariikka Koivisto
ECEero Castren
Eero Castren
Brain-derived neurotrophic factor (BDNF) importantly regulates learning and memory and supports the survival of injured neurons. Reduced BDNF levels have been detected in the brains of Alzheimer’s disease (AD) patients but the exact role of BDNF in the pathophysiology of the disorder remains obscure. We have recently shown that reduced signaling of BDNF receptor TrkB aggravates memory impairment in APPswe/PS1dE9 (APdE9) mice, a model of AD. The present study examined the influence of Bdnf gene deficiency (heterozygous knockout) on spatial learning, spontaneous exploratory activity and motor coordination/balance in middle-aged male and female APdE9 mice. We also studied brain BDNF protein levels in APdE9 mice in different ages showing progressive amyloid pathology. Both APdE9 and Bdnf mutations impaired spatial learning in males and showed a similar trend in females. Importantly, the effect was additive, so that double mutant mice performed the worst. However, APdE9 and Bdnf mutations influenced spontaneous locomotion in contrasting ways, such that locomotor hyperactivity observed in APdE9 mice was normalized by Bdnf deficiency. Obesity associated with Bdnf deficiency did not account for the reduced hyperactivity in double mutant mice. Bdnf deficiency did not alter amyloid plaque formation in APdE9 mice. Before plaque formation (3 months), BDNF protein levels where either reduced (female) or unaltered (male) in the APdE9 mouse cortex. Unexpectedly, this was followed by an age-dependent increase in mature BDNF protein. Bdnf mRNA and phospho-TrkB levels remained unaltered in the cortical tissue samples of middle-aged APdE9 mice. Immunohistological studies revealed increased BDNF immunoreactivity around amyloid plaques indicating that the plaques may sequester BDNF protein and prevent it from activating TrkB. If similar BDNF accumulation happens in human AD brains, it would suggest that functional BDNF levels in the AD brains are even lower than reported, which could partially contribute to learning and memory problems of AD patients.

1 September 2015 in Behavioural Brain Research
Verified
Journal Article
Closed access
SKSusanna Kemppainen
Susanna Kemppainen
PLPäivi Lindholm
Päivi Lindholm
EGEmilia Galli
Emilia Galli
HLHanna-Maija Lahtinen
Hanna-Maija Lahtinen
HKHenna Koivisto
Henna Koivisto
HTHeikki Tanila
Heikki Tanila

1 June 2014 in The Journal of Nutritional Biochemistry
Verified
Journal Article
Closed access
MTMari Takalo
Mari Takalo
AHAnnakaisa Haapasalo
Annakaisa Haapasalo
HMHenna Martiskainen
Henna Martiskainen
KKKaisa M.A. Kurkinen
Kaisa M.A. Kurkinen
HKHenna Koivisto
Henna Koivisto
Mikko HiltunenMikko Hiltunen
Mikko Hiltunen

1 March 2019 in Neurobiology of Aging
Verified
Journal Article
Open access
SGSami Gabbouj
Sami Gabbouj
TNTeemu Natunen
Teemu Natunen
HKHennariikka Koivisto
Hennariikka Koivisto
KJKimmo Jokivarsi
Kimmo Jokivarsi
MTMari Takalo
Mari Takalo
Mikko HiltunenMikko Hiltunen
Mikko Hiltunen
Type 2 diabetes mellitus (T2DM) increases the risk for Alzheimer's disease (AD). Human AD brains show reduced glucose metabolism as measured by [18F]fluoro-2-deoxy-2-D-glucose positron emission tomography (FDG-PET). Here, we used 14-month-old wild-type (WT) and APPSwe/PS1dE9 (APP/PS1) transgenic mice to investigate how a single dose of intranasal insulin modulates brain glucose metabolism using FDG-PET and affects spatial learning and memory. We also assessed how insulin influences the activity of Akt1 and Akt2 kinases, the expression of glial and neuronal markers, and autophagy in the hippocampus. Intranasal insulin moderately increased glucose metabolism and specifically activated Akt2 and its downstream signaling in the hippocampus of WT, but not APP/PS1 mice. Furthermore, insulin differentially affected the expression of homeostatic microglia markers P2ry12 and Cx3cr1 and autophagy in the hippocampus of WT and APP/PS1 mice. We found no evidence that a single dose of intranasal insulin improves overnight memory. Our results suggest that intranasal insulin exerts diverse effects on Akt2 signaling, autophagy, and the homeostatic status of microglia depending on the degree of AD-related pathology.